Building the procedural documentation substrate for specialty medicine.
Synexar is the documentation and revenue-capture layer for the procedures that horizontal ambient scribes can't serve. GI endoscopy pilot-ready. Anesthesia in active design partnership. A category that's quietly worth more than the clinic-visit ambient scribe market everyone's chasing.
Documentation is the bottleneck
Procedural physicians lose 1–2 hours daily to documentation. Legacy systems — Provation, gMed, EndoSoft — were built for data capture, not for clinical flow. They add steps instead of removing them.
Provation, gMed, and EndoSoft have not meaningfully innovated in a decade. The clinic-visit ambient scribes (Abridge, DeepScribe, Nabla) have made documentation faster for office encounters but have not addressed the procedure room — which is where documentation drives revenue capture, not just convenience.
A generational technology transition
The endoscopy suite is undergoing a generational technology transition. ASCs are growing 15% annually. Procedure volumes are rising. Documentation burden is the bottleneck — and the incumbents haven't innovated in a decade.
Built at the point of care
The Synexar platform is built by a practicing gastroenterologist who leads the GI service line at a 15-facility DFW health system, and a founder with 20+ years of technology experience in financial services and deep architecture expertise. Every clinical workflow is designed by the people who do it daily.
Multiple compounding moats
Clinical co-design. Every module is built with clinical leadership at the partner institutions. Workflow lock-in compounds with deployment.
Cross-specialty platform. The same five engines power GI today and anesthesia next. Each new specialty is a fraction of the engineering cost of the first — and a multiplier on enterprise value.
Revenue-cycle alignment. Our design partners include groups operating their own RCM. Our documentation is not just clinically accurate — it's billing-optimized at the source. This is a measurably different value proposition than ambient scribes that produce prose for an EHR to ingest.
Deterministic AI. Every output is traceable to source dictation and rule. CMOs and compliance officers can adopt without the regulatory anxiety of black-box LLMs.
Enterprise-grade from day one. SOC 2 certified; HIPAA certification in progress; BAA available. Azure-hosted with Microsoft Entra ID, row-level security, SMART-on-FHIR validated in Cerner and Epic sandbox environments, HL7/FHIR integration ready.
Predictable, scalable, aligned
Per-procedure / per-OR-room pricing for ASCs, tiered by procedure volume; per-room or hybrid models for health systems. No per-physician fees. Revenue grows with procedure volume — aligned with how healthcare organizations actually grow.
Capital efficient by design.
Pre-seed round closed. One specialty production-ready and entering pilot with a multi-hospital DFW health system, and a second specialty in active design partnership — built with a two-person founding team. Every additional dollar funds distribution, clinical partnerships, and specialty expansion, not foundational engineering.
Domain expertise meets engineering depth
Dr. Ashutosh Gupta — Co-founder & Chief Medical Officer. Board-certified gastroenterologist. Leads the GI service line at a 15-facility DFW health system. Performs colonoscopies, EGDs, and ERCPs. The clinical architect of Synexar GI — every workflow reflects how procedures actually happen.
Raghuram Vadapally — Founder & CEO. 20+ years of technology experience in financial services with deep architecture expertise. Specialized in AI and machine learning — building hands-on with modern AI systems for the past two years. Architected the Synexar platform end-to-end. Based in Frisco, TX. Delaware C-Corp structure; pre-seed round closed.
Restraint is our competitive advantage
We don't chase features. We don't promise what we can't deliver. We don't use opaque AI. We build what physicians actually need, validate it against real clinical workflows, and ship production-grade code. Every feature earns its place.
Deploy in weeks, not months
Azure-hosted. SOC 2 certified; HIPAA certification in progress; BAA available. Microsoft Entra ID SSO. Standard EMR integration via HL7/FHIR. No hardware requirements. No custom installations. A healthcare IT team can evaluate, approve, and deploy Synexar within a single budget cycle.
Built as non-device clinical documentation.
Synexar is structured as non-device clinical documentation software under FDA's Clinical Decision Support guidance (21st Century Cures Act, section 3060). The physician remains the decision-maker. The software organizes, structures, and surfaces information — it does not diagnose, treat, or replace clinical judgment.
For qualified investors.
We share detailed materials — pitch deck, financial model, technical architecture, customer pipeline — privately with accredited investors who reach out. We are not currently soliciting general investment and we conduct fundraising through structured private channels in compliance with applicable securities regulations.
Synexar, Inc. is a Delaware C-Corporation. This page is informational only and does not constitute an offer to sell or solicitation to purchase securities. Any securities offering will be conducted in compliance with applicable federal and state securities laws.